Miramar Capital, LLC Pfizer Inc Transaction History

Miramar Capital, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$39.39 - $51.28 $162,562 - $211,632	-4,127 Reduced 35.95%	7,354 $300,000
Q4 2022 Feb 09, 2023	SELL	$41.75 - $54.5 $212,591 - $277,514	-5,092 Reduced 30.72%	11,481 $588,000
Q3 2022 Nov 10, 2022	SELL	$43.76 - $53.42 $34,526 - $42,148	-789 Reduced 4.54%	16,573 $774,000
Q2 2022 Aug 03, 2022	BUY	$46.53 - $55.17 $2,745 - $3,255	59 Added 0.34%	17,362 $910,000
Q1 2022 May 10, 2022	BUY	$45.75 - $56.69 $520,772 - $645,302	11,383 Added 192.28%	17,303 $896,000
Q2 2021 Aug 06, 2021	BUY	$35.91 - $40.68 $212,587 - $240,825	5,920 New	5,920 $267,000
Q1 2021 Apr 27, 2021	SELL	$33.49 - $37.77 $345,147 - $389,257	-10,306 Closed	0 $0
Q4 2020 Feb 09, 2021	BUY	$33.47 - $42.56 $157,543 - $200,329	4,707 Added 84.07%	10,306 $359,000
Q3 2020 Oct 13, 2020	SELL	$31.75 - $37.25 $31,750 - $37,250	-1,000 Reduced 15.15%	5,599 $206,000
Q2 2020 Aug 05, 2020	BUY	$30.12 - $36.54 $198,761 - $241,127	6,599 New	6,599 $253,000
Q4 2019 Feb 05, 2020	SELL	$32.92 - $37.36 $184,681 - $209,589	-5,610 Closed	0 $0
Q3 2019 Oct 22, 2019	SELL	$32.49 - $42.13 $1.18 Million - $1.54 Million	-36,449 Reduced 86.66%	5,610 $205,000
Q2 2019 Aug 08, 2019	BUY	$36.98 - $41.52 $80,690 - $90,596	2,182 Added 5.47%	42,059 $1.8 Million
Q1 2019 May 13, 2019	SELL	$37.5 - $41.2 $1.5 Million - $1.65 Million	-40,050 Reduced 50.11%	39,877 $1.69 Million
Q4 2018 Feb 14, 2019	BUY	$38.47 - $43.86 $3.07 Million - $3.51 Million	79,927 New	79,927 $3.35 Million

3,218

3.71B

73.2M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $166B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Miramar Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Miramar Capital, LLC with notifications on news.